Alnylam Pharmaceuticals (ALNY) Land & Improvements (2016 - 2018)
Alnylam Pharmaceuticals (ALNY) posted Land & Improvements of $9.1 million for Q4 2018, little changed on a QoQ basis from $9.1 million in Q4 2017, and little changed year-over-year from $9.1 million in Q4 2017.
Alnylam Pharmaceuticals (ALNY) Land & Improvements (2016 - 2018) Analysis & Trends
Alnylam Pharmaceuticals' Land & Improvements history runs 3 years deep, the most recent figure standing at $9.1 million for Q4 2018.
- Quarterly Land & Improvements changed 0.0% year-over-year to $9.1 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $9.1 million (changed 0.0% YoY) and the FY2018 annual result came in at $9.1 million, changed 0.0% from the prior year.
- Land & Improvements was $9.1 million for Q4 2018 at Alnylam Pharmaceuticals, roughly flat from $9.1 million in the prior quarter.
- Across five years, Land & Improvements topped out at $9.1 million in Q4 2016 and bottomed at $9.1 million in Q4 2016.
- A 3-year average of $9.1 million and a median of $9.1 million in 2016 frame the typical range for Land & Improvements.
- Peak annual rise in Land & Improvements reached 0.0% in 2017, while the deepest fall reached 0.0% in 2017.
- Alnylam Pharmaceuticals' Land & Improvements stood at $9.1 million in 2016, then changed by 0.0% to $9.1 million in 2017, then changed by 0.0% to $9.1 million in 2018.
- Business Quant data shows ALNY's Land & Improvements at $9.1 million in Q4 2018, $9.1 million in Q4 2017, and $9.1 million in Q4 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 9.08 Mn |
| Dec 31, 2017 | 9.08 Mn |
| Dec 31, 2016 | 9.08 Mn |